What is Ligand Pharmaceuticals's unrecognized tax benefits?

Ligand Pharmaceuticals (LGND) reported unrecognized tax benefits of $17.08M in Q1 2026.

How has Ligand Pharmaceuticals's unrecognized tax benefits changed year-over-year?

Ligand Pharmaceuticals's unrecognized tax benefits increased by 20.4% year-over-year, from $14.19M to $17.08M.

What is the long-term trend for Ligand Pharmaceuticals's unrecognized tax benefits?

Over 2 years (2023 to 2025), Ligand Pharmaceuticals's unrecognized tax benefits has grown at a 8.7% compound annual growth rate (CAGR), from $14.04M to $16.59M.

Ligand Pharmaceuticals LGND Unrecognized tax benefits

Unrecognized tax benefits at other companies

Ionis PharmaceuticalsIONS

——

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's unrecognized tax benefits?: Ligand Pharmaceuticals (LGND) reported unrecognized tax benefits of $17.08M in Q1 2026.
How has Ligand Pharmaceuticals's unrecognized tax benefits changed year-over-year?: Ligand Pharmaceuticals's unrecognized tax benefits increased by 20.4% year-over-year, from $14.19M to $17.08M.
What is the long-term trend for Ligand Pharmaceuticals's unrecognized tax benefits?: Over 2 years (2023 to 2025), Ligand Pharmaceuticals's unrecognized tax benefits has grown at a 8.7% compound annual growth rate (CAGR), from $14.04M to $16.59M.